Detecting Alzheimer's disease biomarkers with a brief tablet-based cognitive battery: sensitivity to Aβ and tau PET.

Elena TsoyAmelia StromLeonardo IaccarinoSabrina J ErlhoffCollette A GoodeAnne-Marie RodriguezGil D RabinoviciBruce L MillerJoel H KramerKatherine P RankinRenaud La JoieKatherine L Possin

Published in: Alzheimer's research & therapy (2021)

The BHA measures are significantly associated with both Aβ and regional tau in vivo imaging markers and could be used for the identification of patients with suspected AD pathology in clinical practice.

Keyphrases

clinical practice
cerebrospinal fluid
high resolution
computed tomography
cognitive decline
positron emission tomography
pet ct
photodynamic therapy
fluorescence imaging
solid state